When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic IBD.

Hannah K SystromVictoria RaiSiddharth SinghLeonard BaidooAdam S CheifetzShane M DevlinKrisztina B GecsePeter M Irving Gilaad G Kaplan Patricia L KozuchThomas UllmanMiles P SparrowGil Y Melmed Corey Allan Siegel

Published in: The American journal of gastroenterology (2024)

Appropriateness ratings can help guide clinical decision-making about changing therapy to achieve endoscopic remission in asymptomatic patients with IBD until data from ongoing randomized studies are available.

Keyphrases

decision making
ulcerative colitis
double blind
open label
ultrasound guided
electronic health record
placebo controlled
phase iii
big data
disease activity
randomized controlled trial
machine learning
mesenchymal stem cells
rheumatoid arthritis
data analysis
study protocol
bone marrow
artificial intelligence